FDA Inspection 1002165 — Nephron SC, LLC
The FDA completed an inspection of Nephron SC, LLC on Dec 9, 2016 in West Columbia, SC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 9, 2016
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- West Columbia, SC (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)